Abbott Laboratories (ABT) vs State Street SPDR S&P 500 ETF (SPY)

Over the past 10 years, ABT lagged SPY — 11.19% vs 14.89% annualized total return (price plus dividends).

A side-by-side comparison of Abbott Laboratories and State Street SPDR S&P 500 ETF across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

Compare
Different business models: ABT is classified in Healthcare; SPY is classified in Financial Services. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

Total returnABT vs SPY

growth of $100 · dividends reinvested · last 30y
ABT +1921.4%SPY +1866.5%ABT compounded faster
05001k2k2k3kStart $100200120062011201620212026$2,021$1,967
ABT SPY

Metrics side by side

Did ABT beat SPY?

Over the past 10 years, ABT lagged SPY — 11.19% vs 14.89% annualized total return (price plus dividends).

Total return (annualized)

MetricABTSPY
Total return (1Y)-15.45%17.32%
Total return CAGR (3Y)-0.41%18.85%
Total return CAGR (5Y)-0.78%12.50%
Total return CAGR (10Y)11.19%14.89%

SPY is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Frequently asked

Has ABT beaten SPY?
Over the past 10 years, ABT lagged SPY — 11.19% vs 14.89% annualized total return (price plus dividends).

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.